Status:
TERMINATED
Continuous Glucose Monitoring in Critically Ill
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
Medtronic
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical research study is to learn if The Guardian® blood-sugar monitoring device can be used reliably in patients with high blood sugar who are receiving care in the ICU. Researcher...
Detailed Description
The Study Device: The Guardian® blood-sugar monitoring device is designed to automatically record blood sugar levels many times per hour, without requiring multiple fingersticks. It uses a blood suga...
Eligibility Criteria
Inclusion
- Patients in any of our University of Texas collaborative intensive care units.
- Critically ill patients on an insulin infusion protocol
Exclusion
- Patients or their legal representatives who do not consent
- Patients with large areas of skin affected so as not to allow implantation of device.
- Patients \< 18 years of age
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00707434
Start Date
June 1 2008
End Date
September 1 2016
Last Update
March 23 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States, 75390
2
University of Texas Medical Branch at Galveston
Galveston, Texas, United States, 77555
3
University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
4
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030